The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 64 , ISSUE 4 ( October-December, 2022 ) > List of Articles

Original Article

Effect of Hyperglycemia on the Duration of Hospital Stay and Rate of Mortality in Patients of Chronic Obstructive Pulmonary Disease in Acute Exacerbation: A 1-year Hospital-based Observational Study

Gurusamipalayam Sivamani Kandavel, Bhagyashri Patil, Suresh Gautam, Gajanan S Gaude, Jyothi Hattiholi, Kiran Kumar Pujar

Keywords : Chronic obstructive pulmonary disease in acute exacerbation, Duration of hospital stay, Duration of intensive care unit stay hyperglycemia, Random blood sugar, Rate of mortality

Citation Information : Kandavel GS, Patil B, Gautam S, Gaude GS, Hattiholi J, Pujar KK. Effect of Hyperglycemia on the Duration of Hospital Stay and Rate of Mortality in Patients of Chronic Obstructive Pulmonary Disease in Acute Exacerbation: A 1-year Hospital-based Observational Study. Indian J Chest Dis Allied Sci 2022; 64 (4):253-257.

DOI: 10.5005/jp-journals-11007-0032

License: CC BY-NC 4.0

Published Online: 05-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Chronic obstructive pulmonary disease (COPD) is not only a respiratory disease but is also a systemic disease associated with comorbidities such as diabetes mellitus (DM), hypertension, osteoporosis, etc. Diabetes being one of the comorbidities, COPD is thought to be a causative factor for developing insulin resistance. Similarly, poor glycemic control is associated with worsened COPD outcomes. Thus, this study has been taken up to analyze the effect of hyperglycemia on the duration of hospital stay and rate of mortality, and other outcomes in patients with COPD with exacerbation. Methods: It was an observational study conducted for 1 year in KLES Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi, Karnataka, India. A total of 84 patients were enrolled and divided into two groups based on the mean random blood sugar (RBS) levels. Group I had 40 patients with mean RBS <250 mg/dL and group II had 44 patients with mean RBS ≥250 mg/dL. Outcomes and variables of the patients with COPD were compared between both groups. Results: Patients in group II had poor outcomes compared to group I. The mean duration of hospital stays in groups I and group II were 5.43 and 7.34, respectively, with a significant p < 0.0001. The mean duration of intensive care unit (ICU) stay was 3.33 and 4.47 in groups I and II, respectively, which was statistically significant. The rate of mortality in groups I and II was 5.00 and 11.36%, respectively. Conclusion: Patients with hyperglycemia had an increased duration of hospital stay and rate of mortality. Optimal glycemic control plays a significant role in patients with COPD in reducing the severity of exacerbation and mortality.

PDF Share
  1. Lozano R, Naghavi M, Foreman k, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the burden of disease study 2010. Lancet 2012;380(9859):2095–2128. DOI: 10.1016/S0140-6736(12)61728-0.
  2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):e442. DOI: 10.1371/journal.pmed.0030442.
  3. Strojek K, Ziora D, Sroczynski JW, et al. Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia 1992;35(12):1173–1176. DOI: 10.1007/BF00401373.
  4. Küpeli E, Ulubay G, Ulasli SS, et al. Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study. Endocrine 2010;38(1):76–82. DOI: 10.1007/s12020-010-9351-3.
  5. Umpierrez GE, Isaacs SD, Bazargan H, et al. Hyperglycaemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978–982. DOI: 10.1210/jcem.87.3.8341.
  6. Ferreira L, Moniz AC, Carneiro AS, et al. The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. Diabetes Metab Syndr 2018;13(1): 149–153. DOI: 10.1016/j.dsx.2018.08.028.
  7. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: Role of health status, anxiety and depression. Eur Respir J 2005;26(3):414–419. DOI: 10.1183/09031936.05.00078504.
  8. Islam EA, Limsuwat C, Nantsupawat T, et al. The association between glucose levels and hospital outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease. Ann Thorac Med 2015;10(2):94–99. DOI: 10.4103/1817-1737.151439.
  9. Monnier L, Colette C. Glycaemic variability: Should we and can we prevent it? Diabetes care 2008;31(Suppl. 2):S150–S154. DOI: 10.2337/dc08-s241.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.